EPO Patents = 4

Forward Citations = 2

Loading Chart...

11 inventors (with patents filed for the assignee):

Sung Hwan Moon (5 out of 20 patents)

Soo Jin Lee (5 out of 9 patents)

Sung Chan Lee (3 out of 15 patents)

4. Eun Jung Shin (2 out of 2 patents)

5. Yoo-Kyung Goh (2 out of 2 patents)

6. Yun Soo Bae (1 out of 6 patents)

7. Sooho Ban (1 out of 1 patent)

8. Eunsil Lee (1 out of 1 patent)

9. Soo Ho Ban (1 out of 1 patent)

10. Eun Sil Lee (1 out of 1 patent)

11. Hyun Kyung Yu (1 out of 1 patent)

12. Dae Ryong Cha (1 patent)

13. Hee Jong Shin (12 patents)

14. Young Sun Kang (1 patent)

15. Jin Joo Cha (1 patent)

5 patents: Sort by Forward Citations

1. 12509438 - Pyrazole derivative (2025-12-30),

2. 11999718 - Pyrazole derivatives (2024-06-04),

3. 11174240 - Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride (2021-11-16),

4. 10966969 - Therapeutic agent for liver diseases (2021-04-06),

5. 9056886 - Guanosine-rich modified oligonucleotides and antiproliferative activity thereof (2015-06-16),

Aptabio Therapeutics Inc. is a biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases. Our mission is to improve the lives of patients by delivering innovative treatments that target the underlying causes of these debilitating conditions. Through cutting-edge research and collaborations with top academic institutions, we are advancing a pipeline of potential breakthrough therapies. With a strong team of experienced scientists and leaders, we are committed to making a meaningful impact in the field of autoimmune disease research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#126 in Gyeonggi-do

#1,791 in South Korea

Gyeonggi-do, South Korea

Aptabio Therapeutics Inc.